JP2010536857A5 - - Google Patents

Download PDF

Info

Publication number
JP2010536857A5
JP2010536857A5 JP2010521912A JP2010521912A JP2010536857A5 JP 2010536857 A5 JP2010536857 A5 JP 2010536857A5 JP 2010521912 A JP2010521912 A JP 2010521912A JP 2010521912 A JP2010521912 A JP 2010521912A JP 2010536857 A5 JP2010536857 A5 JP 2010536857A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
composition according
peptide monomer
moiety
daltons
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010521912A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010536857A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/070926 external-priority patent/WO2009025957A1/en
Publication of JP2010536857A publication Critical patent/JP2010536857A/ja
Publication of JP2010536857A5 publication Critical patent/JP2010536857A5/ja
Pending legal-status Critical Current

Links

JP2010521912A 2007-08-22 2008-07-23 エリスロポエチン受容体ペプチドの製剤及び使用 Pending JP2010536857A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US95739607P 2007-08-22 2007-08-22
US98975807P 2007-11-21 2007-11-21
PCT/US2008/070926 WO2009025957A1 (en) 2007-08-22 2008-07-23 Erythropoietin receptor peptide formulations and uses

Publications (2)

Publication Number Publication Date
JP2010536857A JP2010536857A (ja) 2010-12-02
JP2010536857A5 true JP2010536857A5 (enExample) 2011-07-21

Family

ID=40194013

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2010521912A Pending JP2010536857A (ja) 2007-08-22 2008-07-23 エリスロポエチン受容体ペプチドの製剤及び使用
JP2010521913A Pending JP2010536858A (ja) 2007-08-22 2008-07-23 エリスロポエチン受容体ペプチド製剤及び用途

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2010521913A Pending JP2010536858A (ja) 2007-08-22 2008-07-23 エリスロポエチン受容体ペプチド製剤及び用途

Country Status (3)

Country Link
EP (1) EP2195002A4 (enExample)
JP (2) JP2010536857A (enExample)
WO (2) WO2009025957A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2709648A4 (en) * 2011-05-19 2015-04-08 Geysen Hendrik M COMPOUNDS FOR BINDING TO THE ERYTHROPOIETIN RECEPTOR
WO2015183545A1 (en) * 2014-05-28 2015-12-03 The Board Of Regents Of The University Of Texas System Novel compounds supports hematopoietic stem cells and red blood cells

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101163683B1 (ko) * 2003-05-12 2012-07-10 아피맥스, 인크. 에리스로포이에틴 수용체에 결합하는 신규의 펩티드
PL1625156T3 (pl) * 2003-05-12 2013-03-29 Affymax Inc Peptydy wiążące się do receptora erytropoetyny
US7919461B2 (en) * 2005-06-03 2011-04-05 Affymax, Inc. Erythropoietin receptor peptide formulations and uses
US7550433B2 (en) * 2005-06-03 2009-06-23 Affymax, Inc. Erythropoietin receptor peptide formulations and uses
US8343953B2 (en) * 2005-06-22 2013-01-01 Astex Therapeutics Limited Pharmaceutical compounds

Similar Documents

Publication Publication Date Title
JP7490735B2 (ja) ジスルフィド含有細胞膜透過ペプチド並びにその製造方法及び使用方法
CN113453720B (zh) 双配体药物偶联体及其用途
ES2950789T3 (es) Polipéptidos de apelina
US20240368227A1 (en) Cyclic cell-penetrating peptides with one or more hydrophobic residues
ES2395413T3 (es) Péptidos que se unen al receptor de eritropoyetina
TWI747178B (zh) 單鏈trail-受體激動劑蛋白質
US20260008812A1 (en) Cell-penetrating peptide compounds
TW202417475A (zh) IL-7Rα結合化合物
WO2016074093A1 (en) Conjugates including an antibody moiety, a polypeptide that traverses the blood-brain barrier, and a cytotoxin
US20260070948A1 (en) Cyclic cell-penetrating peptides with cargo
EP2850201A2 (en) Site-specific labeling and targeted delivery of proteins for the treatment of cancer
US20190309020A1 (en) Cell-penetrating peptide sequences
JP2025509645A (ja) 膜移行ドメイン及びその使用
UA121881C2 (uk) Кон'югат антитіло-уреаза для терапевтичних цілей
CA3112000A1 (en) Alpha(v)beta(6) integrin-binding peptides and methods of use thereof
WO2025116046A1 (ja) ペプチド及び当該ペプチドを含むコンジュゲート
WO2017011812A1 (en) Modified epha4 cyclic peptide antagonists for neuroprotection and neural repair
HK40130456A (en) Bi-ligand drug conjugate and use thereof
WO2015192052A1 (en) Egfr targeting compounds and methods of use thereof
HK40109540A (zh) 反式环辛烯缀合物
EP4562025A2 (en) Cyclic cell-penetrating peptides and uses thereof
HK40120101A (en) Membrane translocation domains and uses thereof
JP2018154565A (ja) ペプチドおよび抗腫瘍剤
BR112018010535B1 (pt) Compostos peptídicos e conjugados peptídicos para o tratamento de câncer por quimioterapia com mediação por um receptor